Skadden advised Eyebiotech Limited, while Gibson, Dunn & Crutcher advised Merck the deal. Merck, known as MSD outside of the United States and Canada, and Eyebiotech...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here